Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
126.24
+1.84 (1.48%)
Jun 4, 2025, 1:44 PM - Market open

Repligen Market Cap

Repligen has a market cap or net worth of $7.09 billion as of June 4, 2025. Its market cap has decreased by -25.78% in one year.

Market Cap
7.09B
Enterprise Value
7.06B
1-Year Change
-25.78%
Ranking
Category
Stock Price
$126.24

Market Cap Chart

Since December 1, 1998, Repligen's market cap has increased from $28.10M to $7.09B, an increase of 25,140.41%. That is a compound annual growth rate of 23.19%.

History

DateMarket Cap% Change
Jun 3, 20256.99B-13.33%
Dec 31, 20248.06B-19.67%
Dec 29, 202310.04B6.78%
Dec 30, 20229.40B-35.80%
Dec 31, 202114.64B45.21%
Dec 31, 202010.08B109.40%
Dec 31, 20194.82B108.18%
Dec 31, 20182.31B46.35%
Dec 29, 20171.58B51.58%
Dec 30, 20161.04B11.88%
Dec 31, 2015932.00M43.85%
Dec 31, 2014647.90M48.87%
Dec 31, 2013435.20M122.72%
Dec 31, 2012195.40M83.30%
Dec 30, 2011106.60M-26.18%
Dec 31, 2010144.40M14.24%
Dec 31, 2009126.40M7.21%
Dec 31, 2008117.90M-41.78%
Dec 31, 2007202.50M137.12%
Dec 29, 200685.40M-29.07%
Dec 30, 2005120.40M39.03%
Dec 31, 200486.60M-33.64%
Dec 31, 2003130.50M57.04%
Dec 31, 200283.10M28.04%
Dec 31, 200164.90M-27.65%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 662.23B
Johnson & Johnson 373.45B
AbbVie 328.75B
Novo Nordisk 305.07B
UnitedHealth Group 273.87B
Abbott Laboratories 232.41B
AstraZeneca 224.00B
Novartis AG 223.92B
Market Cap Rankings